Concepedia

Eva Loranc

EL

5

Publications

463

Citations

5

H-Index

2009

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Universidade Federal de Santa Catarina

The University of Texas at San Antonio

Eva Loranc is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, cell biology, and oncology.

Top concepts

Publications per year

2009–2023

5

Publications

5

EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma

Aparna Gorthi, July Carolina Romero, Eva Loranc et al. · Nature · 2018 · 324 citations · Full text

, , +8

Alkylating Agent–Induced NRF2 Blocks Endoplasmic Reticulum Stress–Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis

Alfeu Zanotto‐Filho, V. Pragathi Masamsetti, Eva Loranc et al. · Molecular Cancer Therapeutics · 2016 · 68 citations · Full text

Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells

Alfeu Zanotto‐Filho, Subapriya Rajamanickam, Eva Loranc et al. · Cancer Letters · 2018 · 29 citations

, , +10

Bimane Fluorescence Scanning Suggests Secondary Structure near the S3-S4 Linker of BK Channels

Nina Semenova, Karin Abarca-Heidemann, Eva Loranc et al. · Journal of Biological Chemistry · 2009 · 28 citations · Full text

, , +20

TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells

Aruna S. Jaiswal, Arijit Dutta, Gayathri Srinivasan et al. · Nucleic Acids Research · 2023 · 14 citations · Full text

Rows per page

1–5 of 5